Influence of liposomal amphotericin B on CD8 T-cell function

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 8, 2001, Pages 2383-2385

  Kretschmar, M ^a   Geginat, G ^a   Bertsch, T ^a   Walter, S ^a   Hof, H ^a   Nichterlein, T ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CD8 ANTIGEN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LISTERIOSIS; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; LIPOSOMES; LISTERIA INFECTIONS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS;

EID: 0034924150     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.8.2383-2385.2001     Document Type: Article

References (15)

1. Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen
2. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis
3. International conference for the development of a consensus on the management and prevention of severe candidal infections
4. Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function
5. Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory, by nonpathogenic Listeria innocua
6. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection
7. Effect of amphotericin B on natural killer cell activity in vitro
8. Lipid formulations of amphotericin B: Recent progress and future directions
9. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis
10. Effect of liposomal amphotericin B on murine macrophages and lymphocytes
11. Murine listeriosis as a model of antimicrobial defense
12. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America
13. Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice
14. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America
15. Lipid formulations of amphotericin B: Clinical efficacy and toxicities